Home › Schizophrenia › Nevada
Schizophrenia clinical trials in Nevada
7 studies for Schizophrenia are looking for participants at sites in Nevada.
Cities in Nevada
A Study to Evaluate the Effect of KarXT on Urological Safety
- IMA Clinical Research Las Vegas, Las Vegas
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Nov 10, 2026 · NCT07221877A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Local Institution - 0144, Las Vegas
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 6, 2026 · NCT07424404Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- Clinical Research of Southern Nevada, LLC, Las Vegas
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Nov 3, 2026 · NCT06229210Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0055, Las Vegas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07379827A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, Las Vegas
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Oct 15, 2026 · NCT0745964752-week Open Label Safety-Tolerability Study
- Redbird Research, Las Vegas
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154Randomized Withdrawal Study in Patients With Schizophrenia
- Vanda Investigational Site, Las Vegas
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.